The recurrent pericarditis market is demonstrating significant growth driven by expanding diagnostic and therapeutic innovations. Focused advancements in anti-inflammatory and immunomodulatory treatments are shaping the market landscape, fostering robust business growth and market opportunities. Market dynamics continue to evolve with increasing prevalence of cardiovascular disorders...